The Biomolecular Core Lab (BCL) provides essential services in molecular biology and genetics to the clinical and research staff at Nemours Children's, Delaware Institutional Development Award/IDeA Networks of Biomedical Research Excellence (INBRE) partner institutions and external clients.
Under the direction of Katherine M Robbins, PhD, the lab provides consultation on experimental design as well as data troubleshooting, training, and mentoring of students and clinical fellows.
The BCL is also a collaborative research laboratory focusing on the study of rare pediatric genetic disorders. Dr. Robbins’ interest is primarily associated with rasopathies, skeletal dysplasias and cancer. One focus of our research is to characterize embryonal rhabdomyosarcoma (ERMS) within our extensive Costello syndrome cohort at the molecular, cytogenetic and functional levels.
Another focus is to elucidate the signaling pathways regulating embryonal rhabdomyosarcoma in our cohort of patients. Costello syndrome is a disorder that affects multiple organ systems and is characterized by short stature, intellectual disability, redundant loose skin, papillomata, and predisposition for heart defects and cancer. Costello syndrome patients have a 15 percent lifetime risk for developing malignances. Furthering our understanding of ERMS will ultimately help us to identify better therapeutic treatment options for these patients. This work is a collaborative effort between Dr. Karen Gripp, MD, and the Biomolecular Core Laboratory.
Dr. Robbins’ research laboratory provides unique educational opportunities to summer students, undergraduates and graduate students at the University of Delaware and partner institutions.
The ultimate goal of this laboratory is to provide biomedical investigators with state-of-the-art technical support and clinicians with tools that can help improve pediatric supportive care and/or therapeutic intervention.
Current Research Group
Katherine M. Robbins, PhD
Director, Nemours Biomolecular Core Lab
Assistant Research Scientist, Nemours Molecular Diagnostic Lab
Operating under strict HIPAA regulations, we are a CLIA-certified site. Our service core unit currently supports the Nemours Molecular Diagnostic DNA sequencing and fragment analysis CLIA-certified tests. We also provide backup services to other cores in the Delaware Valley Network, including DNA sequencing coverage services for the University of Delaware DNA Sequencing and Genotyping Core.
Nemours has a number of service regions. Selecting your region will help us show you the right contact information and the most relevant content for you.